We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
9 hedge funds and large institutions have $321K invested in Decoy Therapeutics in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
73% more capital invested
Capital invested by funds: $186K → $321K (+$135K)
29% more funds holding
Funds holding: 7 → 9 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$174K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$13.7K |
| 4 |
JP Morgan Chase
New York
|
+$2.29K |
Top Sellers
| 1 |
Two Sigma Investments
New York
|
-$19.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.29K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.29K |